Perea S, Fothergill A W, Sutton D A, Rinaldi M G
Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78284-7881, USA.
J Clin Microbiol. 2001 Jan;39(1):385-8. doi: 10.1128/JCM.39.1.385-388.2001.
The in vitro activities of voriconazole against 19 different species of dermatophytes were compared with those of terbinafine, itraconazole, ketoconazole, griseofulvin, and fluconazole. MICs were determined according to a National Committee for Clinical Laboratory Standards broth macrodilution method. Voriconazole appeared more active than ketoconazole, griseofulvin, and fluconazole and less active than itraconazole and terbinafine. Based on these results, voriconazole merits further investigation as a potentially useful agent for the treatment of dermatophytosis.
将伏立康唑对19种不同皮肤癣菌的体外活性与特比萘芬、伊曲康唑、酮康唑、灰黄霉素和氟康唑进行了比较。根据美国国家临床实验室标准委员会的肉汤稀释法测定最低抑菌浓度(MIC)。伏立康唑似乎比酮康唑、灰黄霉素和氟康唑更具活性,而比伊曲康唑和特比萘芬活性低。基于这些结果,伏立康唑作为治疗皮肤癣菌病的潜在有用药物值得进一步研究。